ClinicalTrialsFinder

IBD-unclassified (IBD-U) Clinical Trials in London, Ontario

1 recruitingLondon, Ontario, Canada

Showing 1–1 of 1 trials

Recruiting

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)+1 more
TIDHI Innovation Inc.200 enrolled9 locationsNCT07245394